HOSPIRA FDA Approval ANDA 089650

ANDA 089650

HOSPIRA

FDA Drug Application

Application #089650

Application Sponsors

ANDA 089650HOSPIRA

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION0.005MG/ML;1.5%0LIDOCAINE HYDROCHLORIDE AND EPINEPHRINEEPINEPHRINE; LIDOCAINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1988-06-21
LABELING; LabelingSUPPL2AP1990-03-21
LABELING; LabelingSUPPL3AP1990-11-09
LABELING; LabelingSUPPL4AP2002-01-02

Submissions Property Types

SUPPL1Null0

CDER Filings

HOSPIRA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 89650
            [companyName] => HOSPIRA
            [docInserts] => ["",""]
            [products] => [{"drugName":"LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE","activeIngredients":"EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","strength":"0.005MG\/ML;1.5%","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE","submission":"EPINEPHRINE; LIDOCAINE HYDROCHLORIDE","actionType":"0.005MG\/ML;1.5%","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.